Michael Schultheiss

4PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Systems physiologyPredictive and prognostic markersMicrofluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 04, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.

Tiago de Castro, Sabrina Welland, Leonie Jochheim

|Sep 09, 2024
The Freiburg Index of Post-TIPS Survival accurately predicts mortality in patients with acute decompensation of cirrhosis.

Eric Kalo, Lukas Sturm, Michael Schultheiss

|Sep 27, 2023
Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.

Natascha Roehlen, Fabian Stoehr, Lukas Müller

|Jan 12, 2022
Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding.

Michael Schultheiss, Dominik Bettinger, Lukas Sturm

Pageof 1

Frequent Collaborators

3 joint publications

Dominik Bettinger

2 joint publications

Arndt Weinmann

2 joint publications

Jens U Marquardt

1 joint publications

Natascha Roehlen